Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Operating Leases (2019 - 2022)

Edesa Biotech's Operating Leases history spans 4 years, with the latest figure at $61540.0 for Q1 2022.

  • For Q1 2022, Operating Leases fell 55.45% year-over-year to $61540.0; the TTM value through Mar 2022 reached $61540.0, down 55.45%, while the annual FY2021 figure was $99320.0, 5.15% up from the prior year.
  • Operating Leases for Q1 2022 was $61540.0 at Edesa Biotech, down from $99320.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $185439.0 in Q1 2020 and bottomed at $41725.0 in Q2 2021.
  • The 4-year median for Operating Leases is $138137.0 (2021), against an average of $122645.7.
  • The largest YoY upside for Operating Leases was 5.15% in 2021 against a maximum downside of 76.41% in 2021.
  • A 4-year view of Operating Leases shows it stood at $151514.0 in 2019, then grew by 2.17% to $154800.0 in 2020, then tumbled by 35.84% to $99320.0 in 2021, then tumbled by 38.04% to $61540.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Operating Leases are $61540.0 (Q1 2022), $99320.0 (Q3 2021), and $41725.0 (Q2 2021).